HARTE-HANKS INC(NASDAQ:HHS) stock Fundamental Analysis

Fundamental Rating

Overall HHS gets a fundamental rating of 3 out of 10. We evaluated HHS against 96 industry peers in the Media industry. HHS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HHS has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

HHS had negative earnings in the past year.

In the past year HHS has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: HHS reported negative net income in multiple years.

In multiple years HHS reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -29.77%, HHS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -139.69%, HHS is doing worse than 78.13% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 9.08%, HHS belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.

Measured over the past 3 years, the Average Return On Invested Capital for HHS is above the industry average of 6.73%.

		Industry Rank	Sector Rank
ROA	-29.77%
ROE	-139.69%
ROIC	9.08%

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

1.3 Margins

HHS has a Operating Margin (4.14%) which is in line with its industry peers.

In the last couple of years the Operating Margin of HHS has declined.

HHS has a Gross Margin of 18.80%. This is in the lower half of the industry: HHS underperforms 72.92% of its industry peers.

HHS's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	4.14%
PM (TTM)	N/A
GM	18.8%

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HHS is creating some value.

HHS has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, HHS has more shares outstanding

Compared to 1 year ago, HHS has a worse debt to assets ratio.

2.2 Solvency

HHS has an Altman-Z score of 13.74. This indicates that HHS is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 13.74, HHS belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.

A Debt/Equity ratio of 0.03 indicates that HHS is not too dependend on debt financing.

HHS has a better Debt to Equity ratio (0.03) than 85.42% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	13.74

ROIC/WACC1

WACC9.09%

2.3 Liquidity

HHS has a Current Ratio of 1.53. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.

HHS has a Current ratio of 1.53. This is in the better half of the industry: HHS outperforms 60.42% of its industry peers.

A Quick Ratio of 1.53 indicates that HHS should not have too much problems paying its short term obligations.

HHS has a better Quick ratio (1.53) than 61.46% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.53
Quick Ratio	1.53

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HHS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1763.67%.

Looking at the last year, HHS shows a decrease in Revenue. The Revenue has decreased by -3.26% in the last year.

HHS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.17% yearly.

EPS 1Y (TTM)-1763.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20.89%

Revenue 1Y (TTM)-3.26%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-4.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HHS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 4.40, the valuation of HHS can be described as very cheap.

Based on the Price/Forward Earnings ratio, HHS is valued cheaper than 93.75% of the companies in the same industry.

HHS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.4

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HHS indicates a rather cheap valuation: HHS is cheaper than 95.83% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.03

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HHS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HARTE-HANKS INC

NASDAQ:HHS (5/23/2025, 8:21:28 PM)

After market: 4.65 -0.1 (-2.11%)

4.75

+0.19 (+4.24%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)05-14 2025-05-14

Earnings (Next)08-06 2025-08-06

Inst Owners34.85%

Inst Owner Change-12.94%

Ins Owners9.01%

Ins Owner Change3.05%

Market Cap34.96M

Analysts80

Price Target17.85 (275.79%)

Short Float %0.98%

Short Ratio2.54

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-5.43%

Min Revenue beat(2)-10.78%

Max Revenue beat(2)-0.09%

Revenue beat(4)0

Avg Revenue beat(4)-4.31%

Min Revenue beat(4)-10.78%

Max Revenue beat(4)-0.09%

Revenue beat(8)1

Avg Revenue beat(8)-3.29%

Revenue beat(12)4

Avg Revenue beat(12)-1.03%

Revenue beat(16)8

Avg Revenue beat(16)0.69%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.4
P/S	0.19
P/FCF	N/A
P/OCF	N/A
P/B	1.61
P/tB	1.68
EV/EBITDA	2.03

EPS(TTM)-4.17

EYN/A

EPS(NY)1.08

Fwd EY22.75%

FCF(TTM)-0.91

FCFYN/A

OCF(TTM)-0.41

OCFYN/A

SpS25.13

BVpS2.94

TBVpS2.83

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-29.77%
ROE	-139.69%
ROCE	11.5%
ROIC	9.08%
ROICexc	10.67%
ROICexgc	10.84%
OM	4.14%
PM (TTM)	N/A
GM	18.8%
FCFM	N/A

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

ROICexc(3y)13.82%

ROICexc(5y)N/A

ROICexgc(3y)14.26%

ROICexgc(5y)N/A

ROCE(3y)14.46%

ROCE(5y)N/A

ROICexcg growth 3Y-19.31%

ROICexcg growth 5YN/A

ROICexc growth 3Y-19.72%

ROICexc growth 5YN/A

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

F-Score5

Asset Turnover1.82

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	0.05
Cap/Depr	85.43%
Cap/Sales	2.02%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.53
Quick Ratio	1.53
Altman-Z	13.74

F-Score5

WACC9.09%

ROIC/WACC1

Cap/Depr(3y)122.2%

Cap/Depr(5y)111.4%

Cap/Sales(3y)2.1%

Cap/Sales(5y)1.87%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1763.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20.89%

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.26%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-4.77%

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-15.87%

EBIT growth 3Y-18.2%

EBIT growth 5YN/A

EBIT Next Year198.68%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-187.84%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-128.51%

OCF growth 3YN/A

OCF growth 5YN/A

HARTE-HANKS INC (HHS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens